Loading provider…
Loading provider…
Vascular Neurology Physician in San Diego, CA
NPI: 1316011265Primary Employer
UCSD Medical Group
health.ucsd.edu
HQ Phone
Get M.D. Brett's Phone Numberphone_androidMobile
Get M.D. Brett's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
FL State Medical License
1997 - 2026
CA State Medical License
2000 - 2025

American Board of Psychiatry and Neurology
Neurology

American Board of Psychiatry and Neurology
Vascular Neurology
University of California (San Diego) Medical Center
Fellowship • Vascular Neurology
Until 2001
University of Florida
Residency • Neurology
1997 - 2000
Internship • Internal Medicine
1996 - 1997
Northwestern University
B.A. • Systems’ Biology/ Neurobiology & Physiology
1988 - 1992
University Of Florida College Of Medicine
med.ufl.edu
Medical School
Until 1996
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99223Initial hospital inpatient care, typically 70 minutes per day | 97 | 100 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 73 | 138 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 30 | 39 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 29 | 35 |
| 5 | 99285Emergency department visit, problem with significant threat to life or function | 14 | 14 |
A fractal approach to the features of speech consonants.
Authors: Chouard, C H, Pean, V, Ouayoun, M, Meyer, B
Journal: Acta Otolaryngol
ACCESS: Acute Cerebrovascular Care in Emergency Stroke Systems
Authors: Patrick Lyden
Journal: Arch Neurol
Lead Sponsor: Joseph Broderick, MD
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS), Novo Nordisk A/S
Intervention / Treatment: BIOLOGICAL: Placebo, BIOLOGICAL: Recombinant Activated Factor VII (rFVIIa)
Lead Sponsor: University of California, Irvine
Intervention / Treatment: DEVICE: Telerehabilitation Therapy, BEHAVIORAL: In-Clinic Therapy
Lead Sponsor: Washington University School of Medicine
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)
Intervention / Treatment: DRUG: Placebo, DRUG: Argatroban, DRUG: Eptifibatide